chr14-50912167-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 1P and 4B. PP3BS2
The ENST00000216392.8(PYGL):c.1757C>T(p.Thr586Met) variant causes a missense change. The variant allele was found at a frequency of 0.000584 in 1,614,072 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. T586T) has been classified as Likely benign.
Frequency
Consequence
ENST00000216392.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PYGL | NM_002863.5 | c.1757C>T | p.Thr586Met | missense_variant | 14/20 | ENST00000216392.8 | NP_002854.3 | |
PYGL | NM_001163940.2 | c.1655C>T | p.Thr552Met | missense_variant | 13/19 | NP_001157412.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PYGL | ENST00000216392.8 | c.1757C>T | p.Thr586Met | missense_variant | 14/20 | 1 | NM_002863.5 | ENSP00000216392 | P1 | |
PYGL | ENST00000532462.5 | c.1757C>T | p.Thr586Met | missense_variant | 14/20 | 1 | ENSP00000431657 | |||
PYGL | ENST00000544180.6 | c.1655C>T | p.Thr552Met | missense_variant | 13/19 | 2 | ENSP00000443787 |
Frequencies
GnomAD3 genomes AF: 0.000440 AC: 67AN: 152188Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000418 AC: 105AN: 251452Hom.: 1 AF XY: 0.000397 AC XY: 54AN XY: 135900
GnomAD4 exome AF: 0.000599 AC: 875AN: 1461884Hom.: 2 Cov.: 34 AF XY: 0.000567 AC XY: 412AN XY: 727244
GnomAD4 genome AF: 0.000440 AC: 67AN: 152188Hom.: 1 Cov.: 32 AF XY: 0.000417 AC XY: 31AN XY: 74356
ClinVar
Submissions by phenotype
Glycogen storage disease, type VI Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 10, 2023 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 23, 2023 | The c.1757C>T (p.T586M) alteration is located in exon 14 (coding exon 14) of the PYGL gene. This alteration results from a C to T substitution at nucleotide position 1757, causing the threonine (T) at amino acid position 586 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jun 20, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at